Marquette Asset Management, LLC Vertex Pharmaceuticals Inc Transaction History

Marquette Asset Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 02, 2024	SELL	$343.0 - $410.68 $686 - $821	-2 Reduced 3.28%	59 $24,000
Q3 2023 Oct 27, 2023	SELL	$338.18 - $362.46 $5,749 - $6,161	-17 Reduced 21.79%	61 $21,000
Q2 2023 Jul 28, 2023	BUY	$314.42 - $351.91 $24,524 - $27,448	78 New	78 $27,000
Q2 2019 Jul 23, 2019	SELL	$164.61 - $190.37 $5,925 - $6,853	-36 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$163.73 - $194.7 $5,894 - $7,009	36 New	36 $7,000

1,724

222M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $119B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Marquette Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Marquette Asset Management, LLC with notifications on news.